These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Protecting research subjects after consent: the case for the "research intermediary. Reiser SJ; Knudson P IRB; 1993; 15(2):10-1. PubMed ID: 11651567 [No Abstract] [Full Text] [Related]
24. Protection of human subjects. United States Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819 [No Abstract] [Full Text] [Related]
25. Human subject research review in the Department of Defense. Winter PE IRB; 1984; 6(3):9-10. PubMed ID: 11649568 [No Abstract] [Full Text] [Related]
26. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials. Weijer C IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912 [No Abstract] [Full Text] [Related]
27. IRBs and pharmaceutical company funding of research. Jellinek MS; Levine RJ IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693 [No Abstract] [Full Text] [Related]
28. Testing drugs in pediatric populations: the FDA mandate. Tauer CA Account Res; 1999; 7(1):37-58. PubMed ID: 11657562 [No Abstract] [Full Text] [Related]
29. Human experimentation: the review process in practice. Cowan DH Case West Reserve Law Rev; 1975; 25(3):533-64. PubMed ID: 11661165 [No Abstract] [Full Text] [Related]
30. IRB review of adverse events in investigational drug studies. Prentice ED; Gordon B IRB; 1997; 19(6):1-4. PubMed ID: 11656910 [No Abstract] [Full Text] [Related]
31. Changing federal regulation of IRBs, Part III: social research and the proposed DHEW regulations. Gray BH IRB; 1980 Jan; 2(1):1-5+. PubMed ID: 11661793 [No Abstract] [Full Text] [Related]
32. The federal policy for the protection of human subjects. Porter JP IRB; 1991; 13(5):8-9. PubMed ID: 11651250 [No Abstract] [Full Text] [Related]
33. Position statement of the AFCR on FDA proposal to assign scientific review of new drugs for human use to local institutional review boards. American Federation for Clinical Research Clin Res; 1982 Feb; 30(1):27-8. PubMed ID: 11653562 [No Abstract] [Full Text] [Related]
34. Ethical and legal considerations in dental caries research involving human subjects. Branson R J Dent Res; 1980 Jul; 59(Special Issue C):1214-364. PubMed ID: 11651755 [No Abstract] [Full Text] [Related]
35. Bill of rights for research subjects. Prentice ED; Reitemeier PJ; Antonson DL; Kelso TK; Jameton A IRB; 1993; 15(2):7-9. PubMed ID: 11651568 [No Abstract] [Full Text] [Related]
36. Changing federal regulation of IRB's: the Commission's recommendations and the FDA's proposals. Levine RJ IRB; 1979 Mar; 1(1):1-3+. PubMed ID: 11662736 [No Abstract] [Full Text] [Related]
37. Special informed consent requirements are included in protocol review procedures. Maloney DM Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274 [No Abstract] [Full Text] [Related]
40. Institutional review boards and public health research: an analysis. Hogue LL Univ Ark Little Rock Law J; 1978; 1(2):428-54. PubMed ID: 11661619 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]